Track topics on Twitter Track topics that are important to you
DETROIT, July 20, 2015 (GLOBE NEWSWIRE) -- Covisint Corporation (Nasdaq:COVS), a leading cloud platform provider enabling Internet of Things (IoT) and Identity Management-centric (IdM) solutions, will release financial results for its first quarter fiscal 2016 – ended June 30, 2015 – after the U.S. stock market close on Thursday, August 6, 2015. Covisint will also hold a conference call to discuss these results at 5:00 p.m. (ET) that day.
The U.S. toll free dial-in for the conference call is 1-877-407-4018, and the international dial-in number is 1-201-689-8471. No passcode is required. A live webcast of the conference call will also be available on the investor relations page of the company's website at investors.covisint.com.
For those unable to participate in the conference call, a replay will be available after the conclusion of the earnings call on August 6, 2015, through August 13, 2015. The U.S. toll-free replay dial-in number is 1-877-870-5176 and the international replay dial-in number is 1-858-384-5517. The replay passcode is 13614247.
About Covisint Corporation
Covisint provides an open, developer-friendly, enterprise-class cloud platform to facilitate the rapid development and deployment of Internet of Things (IoT), Identity Management (IdM), and B2B collaboration solutions. Our platform enables users to securely identify, authenticate and connect users, devices, applications and information, and has been successfully operating globally at enterprise scale for over 12 years. Today, the Covisint platform enables more than 3,000 organizations to connect with more than 212,000 business partners and customers, and supports more than $4 billion in ecommerce transactions annually. Learn more at www.covisint.com.
CONTACT: Investor Relations Contact 866.319.7659 firstname.lastname@example.org Media Contact Brad Schechter 248.483.2097 email@example.com For Sales and Marketing Information Covisint Corporation, 26533 Evergreen Road, Suite 500 Southfield, MI 48076 (800) 229-4125, http://www.covisint.comNEXT ARTICLE
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...